Moreover, monocytes and basophils, which are significantly increased in CML patients, were found to express high levels of PD-L1, suggesting that these cells may suppress anti-tumor immunity. The gene discussed is CD274; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.